Jefferies analyst Cui Cui maintained a Buy rating on Wuxi Biologics (Cayman) (WXIBF – Research Report) today and set a price target of ...

We forecast WuXi's revenue growth to be slower than that of other well-established peers. The risk is high that the US Biosecure Act will become law, and we expect global pharmaceutical or ...

Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions for ...

WuXi Biologics reports 32.5% North American revenue growth in 2024, driven by deals with BioNTech and Candid Therapeutics, ...

Shortly after WuXi AppTec provided an upbeat outlook for 2025, several other WuXi sibling companies are coming forward with ...

WuXi Biologics (2269.HK), a leading global CRDMO, has once again earned top recognition at the 2025 CDMO Leadership Awards, ...

Launching the Water Excellence Stewardship (WES) program to advance UN Sustainable Development Goal 6 (SDG6) Contributing to the 2025 World Water Day campaign to ensure the availability of water and ...

Oktober 2023 machte der Bundeskanzler klar: „In diesem Moment gibt es für Deutschland nur einen Platz: den Platz an der Seite Israels.“ Die Geschichte Deutschlands und die aus dem Holocaust ...

ROCKVILLE, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases ...

1 Day WXIBF 4.23% DJIA -1.69% S&P 500 -1.97% Health Care/Life Sciences -0.14% ...

1 Day WXXWY 0.91% DJIA 1.14% S&P 500 1.39% Health Care/Life Sciences 0.19% ...

Das Gastgewerbe in Deutschland hat im Januar 2025 nach vorläufigen Ergebnissen des Statistischen Bundesamtes (Destatis) kalender- und saisonbereinigt real (preisbereinigt) 2,7 % und nominal (nicht ...